22 results
8-K
EX-10.1
MIRA
Mira Pharmaceuticals Inc
28 Jun 24
Departure of Directors or Certain Officers
5:00pm
of Employee’s duties or that is injurious to the Company, including without limitation injurious to the reputation of the Company, (iv) Employee’s
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
the pricing and reimbursement of Ketamir-2 and MIRA-55 and our other product candidates and could have a material adverse effect on our business, reputation … demand for Ketamir-2, MIRA-55 or our other product candidates if such product candidates are approved;
injury to our reputation;
withdrawal of clinical
8-K
EX-10.1
MIRA
Mira Pharmaceuticals Inc
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
proposed settlement of any such Claim by the other Party might be expected to affect adversely the Indemnitee’s tax status, reputation, the ability
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
effect on our business, reputation, results of operations and financial condition.
We expect to face intense competition, often from companies … reputation;
withdrawal of clinical trial participants;
costs of related litigation;
substantial monetary awards to patients and others;
increased cost
424B1
r7w1x3g0 1vy
4 Aug 23
Prospectus with pricing info
12:59pm
S-1
EX-10.9
er5td1g
29 Jun 23
IPO registration
4:39pm
S-1
EX-99.5
06j1ztd4bh
29 Jun 23
IPO registration
4:39pm
S-1
extj6mg6j9wrx9 vzn
29 Jun 23
IPO registration
4:39pm
S-1
EX-10.8
ta1f20cv2k7q8j53s
29 Jun 23
IPO registration
4:39pm
S-1
EX-10.1
qznyyg7x4qh6tqni
29 Jun 23
IPO registration
4:39pm
S-1
EX-10.7
76du0c7j6ogx9bn
29 Jun 23
IPO registration
4:39pm
DRS/A
EX-10.7
h0t0b33
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-10.9
yqdq18
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
yn0b95dsx5m9aei0dm14
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-10.10
aj9lc2kt px75
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-10.8
runua6mb v8
8 Jun 23
Draft registration statement (amended)
12:00am